CONSOLIDATED STATEMENTS OF EQUITY - USD ($)	Total	Common Stock	Preferred stock Series A Preferred	Preferred stock Series C Preferred	Additional Paid-In Capital	Retained Earnings	Non-controlling Interest
Beginning balance at Dec. 31, 2018	$ 28,809,044	$ 40,175	$ 420	$ 0	$ 75,131,122	$ (47,800,886)	$ 1,438,213
Beginning balance (in shares) at Dec. 31, 2018		40,174,821	419,859	0
Increase (Decrease) in Stockholders' Equity
Share based compensation expense	143,063				143,063
Conversion of Series B1 Preferred stock to common	150,010	$ 96			149,914
Conversion of Series B1 Preferred stock to common (in shares)		96,160
Dividends on Series B and B1	(406,795)					(406,795)
Accretion of discount on Series B and B1	(560,675)					(560,675)
Net income (loss)	(5,068,995)					(4,963,564)	(105,431)
Ending balance at Mar. 31, 2019	23,065,652	$ 40,271	$ 420	$ 0	75,424,099	(53,731,920)	1,332,782
Ending balance (in shares) at Mar. 31, 2019		40,270,981	419,859	0
Beginning balance at Dec. 31, 2018	28,809,044	$ 40,175	$ 420	$ 0	75,131,122	(47,800,886)	1,438,213
Beginning balance (in shares) at Dec. 31, 2018		40,174,821	419,859	0
Increase (Decrease) in Stockholders' Equity
Exercise of options to purchase common stock (in shares)		78,425
Ending balance at Sep. 30, 2019	20,780,014	$ 41,850	$ 420		79,719,745	(59,788,939)	806,938
Ending balance (in shares) at Sep. 30, 2019		41,849,406	419,859
Beginning balance at Mar. 31, 2019	23,065,652	$ 40,271	$ 420	$ 0	75,424,099	(53,731,920)	1,332,782
Beginning balance (in shares) at Mar. 31, 2019		40,270,981	419,859	0
Increase (Decrease) in Stockholders' Equity
Exercise of options to purchase common stock	4,500	$ 76			4,424
Exercise of options to purchase common stock (in shares)		75,925
Share based compensation expense	171,002				171,002
Distribution to noncontrolling	(285,534)						(285,534)
Dividends on Series B and B1	(412,875)					(412,875)
Accretion of discount on Series B and B1	(532,925)					(532,925)
Net income (loss)	(629,765)					(427,436)	(202,329)
Ending balance at Jun. 30, 2019	21,380,055	$ 40,347	$ 420	$ 0	75,599,525	(55,105,156)	844,919
Ending balance (in shares) at Jun. 30, 2019		40,346,906	419,859	0
Increase (Decrease) in Stockholders' Equity
Exercise of options to purchase common stock	2,575	$ 3			2,572
Exercise of options to purchase common stock (in shares)		2,500
Adjustment of carrying mount of non-controlling interest	970,809				970,809
Share based compensation expense	159,426				159,426
Accretion of redeemable non-controlling interest to redemption value	(1,849,930)					(1,849,930)
Issuance of common stock and warrants	2,216,711	$ 1,500			2,987,413	(772,202)
Issuance of common stock and warrants (in shares)		1,500,000
Dividends on Series B and B1	(419,096)					(419,096)
Accretion of discount on Series B and B1	(550,774)					(550,774)
Net income (loss)	(1,129,762)					(1,091,781)	(37,981)
Ending balance at Sep. 30, 2019	20,780,014	$ 41,850	$ 420		79,719,745	(59,788,939)	806,938
Ending balance (in shares) at Sep. 30, 2019		41,849,406	419,859
Beginning balance at Dec. 31, 2019	23,102,026	$ 43,396	$ 420	$ 0	81,527,351	(59,246,514)	777,373
Beginning balance (in shares) at Dec. 31, 2019		43,395,563	419,859	0
Increase (Decrease) in Stockholders' Equity
Purchase of shares of consolidated subsidiary	(71,171)				(71,171)
Adjustment of carrying mount of non-controlling interest	9,091,068				9,091,068
Share based compensation expense	163,269				163,269
Conversion of Series B1 Preferred stock to common	3,368,474	$ 2,159			3,366,315
Conversion of Series B1 Preferred stock to common (in shares)		2,159,278
Dividends on Series B and B1	(344,499)					(344,499)
Accretion of discount on Series B and B1	(932,003)					(932,003)
Accretion of redeemable non-controlling interest to redemption value	(10,966,349)					(10,966,349)
Net income (loss)	2,908,128					2,788,860	119,268
Ending balance at Mar. 31, 2020	26,318,943	$ 45,555	$ 420	$ 0	94,076,832	(68,700,505)	896,641
Ending balance (in shares) at Mar. 31, 2020		45,554,841	419,859	0
Beginning balance at Dec. 31, 2019	23,102,026	$ 43,396	$ 420	$ 0	81,527,351	(59,246,514)	777,373
Beginning balance (in shares) at Dec. 31, 2019		43,395,563	419,859	0
Increase (Decrease) in Stockholders' Equity
Purchase of shares of consolidated subsidiary	(71,171)
Adjustment of carrying mount of non-controlling interest	9,091,068
Ending balance at Sep. 30, 2020	11,179,859	$ 45,555	$ 420	$ 0	94,404,520	(84,323,362)	1,052,726
Ending balance (in shares) at Sep. 30, 2020		45,554,841	419,859	0
Beginning balance at Mar. 31, 2020	26,318,943	$ 45,555	$ 420	$ 0	94,076,832	(68,700,505)	896,641
Beginning balance (in shares) at Mar. 31, 2020		45,554,841	419,859	0
Increase (Decrease) in Stockholders' Equity
Share based compensation expense	156,539				156,539
Dividends on Series B and B1	(360,217)					(360,217)
Accretion of discount on Series B and B1	(539,235)					(539,235)
Accretion of redeemable non-controlling interest to redemption value	(1,381,889)					(1,381,889)
Net income (loss)	(9,015,517)					(8,997,638)	(17,879)
Ending balance at Jun. 30, 2020	15,178,624	$ 45,555	$ 420	$ 0	94,233,371	(79,979,484)	878,762
Ending balance (in shares) at Jun. 30, 2020		45,554,841	419,859	0
Increase (Decrease) in Stockholders' Equity
Share based compensation expense	171,149				171,149
Dividends on Series B and B1	(591,777)					(591,777)
Accretion of discount on Series B and B1	(29,157)					(29,157)
Accretion of redeemable non-controlling interest to redemption value	(1,287,559)					(1,287,559)
Net income (loss)	(2,261,421)					(2,435,385)	173,964
Ending balance at Sep. 30, 2020	$ 11,179,859	$ 45,555	$ 420	$ 0	$ 94,404,520	$ (84,323,362)	$ 1,052,726
Ending balance (in shares) at Sep. 30, 2020		45,554,841	419,859	0